RecallRadar

FDA Drug recall D-1174-2022

Eszopiclone Tablets, USP 1 mg, packaged in 30-count bottles, Rx Only, Manufactured for: Macleods Pharma USA, Inc., Plainsboro, NJ 08536, Ma…

On 2022-07-13 the FDA classified a Class II recall of Eszopiclone Tablets, USP 1 mg, packaged in 30-count bottles, Rx Only, Manufactured for: Macleods Pharma USA, Inc., Plainsboro, NJ 08536, Ma… by Macleods Pharma Usa, citing shortfill: customer complaints of one to three tablets were reported missing from 30 count bottles.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-1174-2022
ClassificationClass II
Statusterminated
Initiated2022-06-16
Published2022-07-13
Last updated2026-09-13 11:52 UTC
CompanyMacleods Pharma Usa
DistributionUS

Product

Eszopiclone Tablets, USP 1 mg, packaged in 30-count bottles, Rx Only, Manufactured for: Macleods Pharma USA, Inc., Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceuticals Ltd., Baddi, Himachal Pradesh, INDIA, NDC 33342-299-07

Reason

Shortfill: customer complaints of one to three tablets were reported missing from 30 count bottles.

Identifiers

ndc33342-299-07
ndc33342-299-11
ndc33342-299-44
ndc33342-299-12
ndc33342-300-11
ndc33342-300-44
ndc33342-300-12
ndc33342-301-11
ndc33342-301-44
ndc33342-301-12
code_infoLot #: BEK2009A Exp: 11/2023

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1174-2022%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.